September 11, 2020
Health Canada indication reflects REWIND findings
Health Canada has approved dulaglutide to reduce the risk of non-fatal stroke in adults with type 2 diabetes mellitus who...
Read MoreSeptember 11, 2020
Health Canada has approved dulaglutide to reduce the risk of non-fatal stroke in adults with type 2 diabetes mellitus who...
Read MoreSeptember 10, 2020
Improving the post-operative patient experience using a new model of virtual care is the subject of a presentation about PHRI’s...
Read MoreSeptember 8, 2020
Slowly and carefully, PHRI employees are making their way back into their work-home, the David Braley Cardiac Vascular Stroke Research...
Read MoreAugust 25, 2020
Talk about big online meetings! Up to 22,000 participants at once attended the free, virtual sessions at ESC Congress: The...
Read MoreAugust 25, 2020
PHRI Scientist Richard Whitlock has been named the Canada Research Chair in Cardiovascular Surgery, a new Tier 2 Chair, funded...
Read MoreAugust 13, 2020
The academic proficiency of the biostatistical team at PHRI was again demonstrated with the recent publication of “Projecting effectiveness after ending...
Read MoreBack To Top